Conditional expression of mutant K-ras (constitutively active mutation G12D) with TGF-β receptor type II knockout in pancreas also developed pancreatic cancer in mice, accompanied by desmoplasia. This evidence concerns the gene KRAS and pancreatic neoplasm.